Whole-exome sequencing data from 151 HNSCC tumor samples demonstrated that 31% of the tumors had mutations in the PI3K oncogenic pathway (Lui et al., 2013). This evidence concerns the gene PIK3CA and head and neck squamous cell carcinoma.